OncoTherapy Science, Inc. Stock: price and insider trades · Japan

This page follows insider dealings at OncoTherapy Science, Inc. as filed with EDINET (Japan FSA), a company from the Health Care sector. From 18 October 2025 to 18 October 2026, the disclosure feed for OncoTherapy Science, Inc. logged 26 filings by 2 insiders.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Across the 3,427 companies tracked on its exchange, the median is 3 filings; at 26 filings, this issuer sits above that mark.

No insider has bought OncoTherapy Science, Inc. shares on the open market in the past twelve months. Typically, a trade is published a median of 3 days after it takes place. This delay matters because a trade only becomes useful information once it is public.

For comparison within the same sector, see the insider buying recorded at Cooper Companies, Inc. and Anixa Biosciences Inc. Every figure here comes from the filings published by EDINET (Japan FSA) and describes the past, not future prices; it is not investment advice.